Glenmark receives USFDA approval for Metronidazole Vaginal Gel 075Percentage

30 Jan 2022 , 01:32 AM

Glenmark Pharmaceuticals has received final approval by the United States Food Drug Administration US FDA for Metronidazole Vaginal Gel 075Percentage the generic version of MetroGel-Vaginal1 Gel 075Percentage of Bausch Health US LLC According to IQVIA sales data for the 12 month period ending November 2021 the MetroGelVaginal Gel 075Percentage market achieved annual sales of approximately $604 million